Rheumatologic Diseases

Clinical Decision Support Tool

Veröffentlicht von: @Point of Care

Beschreibung

Rheumatologic Diseases @Point of Care™ (PoC) provides a streamlined clinical decision support tool for clinicians who specialize in rheumatologic diseases including: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Juvenile Idiopathic Arthritis to obtain content when it is needed, keep track of their patients—enabling better decisions, better outcomes, and better care.
Featuring Ask With Watson (@sk), clinicians use @Point of Care™ Clinician Suite apps to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. The Ask With Watson, confidence-rated answers happen more quickly to efficiently incorporate best treatment options and decisions are made faster to improve patient outcomes at the point of care.
Each @Point of Care™ Clinician Suite app is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
• Receive detailed information regarding your patients' health such as: Medications and treatments; Symptoms and side effects; Charts that record test results, medication adherence, and more
• Voice-activate commands for Watson, Patient Access and Clinical resources
• Read-aloud feature for hands-free listening to medical texts
• App Prescriber lets you prescribe one of our many patient apps to your patients
Ausblenden Mehr anzeigen...

Screenshots

Rheumatologic Diseases Häufige Fragen

  • Ist Rheumatologic Diseases kostenlos?

    Ja, Rheumatologic Diseases ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Rheumatologic Diseases seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Rheumatologic Diseases?

    Rheumatologic Diseases ist kostenlos.

  • Wie hoch ist der Umsatz von Rheumatologic Diseases?

    Um geschätzte Einnahmen der Rheumatologic Diseases-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Kanada noch nicht bewertet.
Bewertungsverlauf

Rheumatologic Diseases Bewertungen

Keine Bewertungen in Kanada
Die App hat noch keine Bewertungen in Kanada.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

Rheumatologic Diseases Konkurrenten

Name
rheumHub
Rheumatology Dictionary
Animated Medical Dictionary
DAS Calculator
DAS28/ACR-EULAR criteria
for rheumatoid arthritis
RheumaHelper
Your Rheumatology Assistant
Guidelines And Criteria
ESIMR: Clinical Case Challenge
RHAPP ACE
ESIMR: UnRavelling Spondyloart
ESIMR: Uncovering The Hand Rad

Rheumatologic Diseases Installationen

Letzte 30 Tage

Rheumatologic Diseases Umsatz

Letzte 30 Tage

Rheumatologic Diseases Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Rheumatologic Diseases mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.